glp 1 safe for thyroid patients Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning The Truth About GLP-1s, Thyroid

Patients taking tirzepatide 10 mg achieved an average of 19.5% weight loss, and patients taking tirzepatide 15 mg achieved an average of 20.9% weight loss

Always consult a licensed medical provider before beginning any GLP-1 program.

The FDA's stated basis: no identified clinical need for outsourcing facilities to compound these drugs from bulk substances when FDA-approved alternatives are available

Zhang, L

As always, consult with your healthcare provider to determine what is best for you

However, microdosing is considered an off-label practice with limited clinical research, and professional organizations including the American Diabetes Association do not formally endorse it